Xenoport
A biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD637m (Public information from May 2016)
Santa Clara United States (HQ)
Authorizing premium user...